| 21st Apr 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 21st Apr 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 21st Apr 2020 7:00 am |
RNS |
Notice of GM |
| 16th Apr 2020 9:05 am |
RNS |
Second Price Monitoring Extn |
| 16th Apr 2020 9:00 am |
RNS |
Price Monitoring Extension |
| 15th Apr 2020 4:31 pm |
RNS |
Further Re: Block Listing Application |
| 15th Apr 2020 11:05 am |
RNS |
Second Price Monitoring Extn |
| 15th Apr 2020 11:00 am |
RNS |
Price Monitoring Extension |
| 15th Apr 2020 7:00 am |
RNS |
Block Listing Application |
| 15th Apr 2020 7:00 am |
RNS |
Issue of Equity |
| 14th Apr 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 14th Apr 2020 4:37 pm |
RNS |
Price Monitoring Extension |
| 14th Apr 2020 11:06 am |
RNS |
Second Price Monitoring Extn |
| 14th Apr 2020 11:01 am |
RNS |
Price Monitoring Extension |
| 9th Apr 2020 7:00 am |
RNS |
Tiziana Develops Treatment For COVID-19 Patients |
| 16th Mar 2020 5:21 pm |
RNS |
Closing of Offer |
| 12th Mar 2020 7:00 am |
RNS |
Tiziana U.S. Follow-On Offering of $10 million |
| 11th Mar 2020 7:00 am |
RNS |
TZLS-501 / COVID-19 |
| 20th Feb 2020 10:30 am |
RNS |
Result of GM |
| 17th Feb 2020 7:00 am |
RNS |
Proposed U.S. Public Offering of ADSs |
| 4th Feb 2020 12:00 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Feb 2020 7:00 am |
RNS |
Notice of GM |
| 23rd Jan 2020 7:00 am |
RNS |
Filing of SEC Form F-3 |
| 21st Jan 2020 2:45 pm |
RNS |
Director Appointment |
| 14th Jan 2020 11:00 am |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2020 7:00 am |
RNS |
Proposed Cancellation from AIM |
| 9th Jan 2020 7:00 am |
RNS |
Further re: Foralumab Phase 1 Trial |
| 2nd Jan 2020 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 4th Dec 2019 7:00 am |
RNS |
Foralumab Phase 1 Trial |
| 20th Nov 2019 7:00 am |
RNS |
Issue of Equity and Directorate Change |
| 1st Nov 2019 7:00 am |
RNS |
Issue of CLN |
| 30th Oct 2019 10:31 am |
RNS |
Change to ADS ratio |
| 30th Sep 2019 7:00 am |
RNS |
Half-year Report |
| 16th Sep 2019 7:00 am |
RNS |
Further re: Update on IND Application |
| 10th Sep 2019 7:00 am |
RNS |
Phase 1 Clinical Data |
| 4th Sep 2019 7:00 am |
RNS |
Phase 2a Clinical Data |
| 21st Aug 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 21st Aug 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 6th Aug 2019 7:00 am |
RNS |
Proposed U.S. Public Offering |
| 22nd Jul 2019 7:00 am |
RNS |
Phase 2a Clinical Data |
